Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03195244 · ClinicalTrials.gov registry record · NA

Aquatic Therapy and Autism Spectrum Disorders

A NA study, sponsored by Sloan W. Rush, MD.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT03195244: Completed NA study, sponsored by Sloan W. Rush, MD.

NCT03195244 is a NA study that has completed, run by Sloan W. Rush, MD. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03195244, a NA study, has completed, sponsored by Sloan W. Rush, MD.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

To compare the efficacy of one-on-one versus group-based aquatic therapy on the social interactions, behaviors and physical activities of children with autism spectrum disorders (ASDs).

Primary Outcome

Survey

Interventions

  • OTHER Aquatic Physical Therapy

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2017-06-12
Est. Completion 2022-04-12
Phase NA
Sloan W. Rush, MD

3 total trials

What the finished NCT03195244 record still lists

NCT03195244 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Aquatic Physical Therapy is the first listed.

NCT03195244 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03195244 about?

NCT03195244 is a clinical study titled "Aquatic Therapy and Autism Spectrum Disorders". To compare the efficacy of one-on-one versus group-based aquatic therapy on the social interactions, behaviors and physical activities of children with autism spectrum disorders (ASDs).

What is the current status of trial NCT03195244?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2017-06-12. Estimated completion is 2022-04-12.

What interventions are being tested in trial NCT03195244?

The interventions under investigation include: Aquatic Physical Therapy (OTHER).

Who is sponsoring clinical trial NCT03195244?

This trial is sponsored by Sloan W. Rush, MD, which has 3 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03195244's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03195244, the US trial registry maintained by the National Library of Medicine. NCT03195244 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.